Combination of chemotherapy and mild hyperthermia enhances the anti-tumor effects of cisplatin and adriamycin in human bladder cancer T24 cells in vitro

Experimental and Therapeutic Medicine

Volumn 1, Issue 2, 2010, Pages 319-323

  Itoh, Youko ^a   Yamada, Yoshiaki ^a   Kazaoka, Yoshiaki ^a   Ishiguchi, Tsuneo ^a   Honda, Nobuaki ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti tumor drug; Chemotherapy; Combined effect; Human bladder cancer cells; Mild hyperthermia

Indexed keywords

CISPLATIN; DOXORUBICIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IN VITRO STUDY; SURVIVAL RATE; TEMPERATURE SENSITIVITY;

EID: 77955282556     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm_00000049     Document Type: Article

References (24)

1. Sternberg CN, Yagoda A, Scher HI, et al: Preliminary results of M-VAC(methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 133: 403-407, 1985.
2. Masse HM, Hansen SW, Robert JT, et al: Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin and cisplatin in advanced or metastatic bladder cancer; results of a large, randomized, multinational, multicancer, phase III study. J Clin Oncol 18: 3068-3077, 2000.
3. Saxman SB, Propert KJ, Einborn LH, et al: Long-term follow-up of a phase IIIintergroup study of cisplatin alone or in combination with methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma; a cooperative group study. J Clin Oncol 15: 2564-2569, 1997.
4. Sternberg CN, Yagoda A, Scher HI, et al: Methotrexate, vinblastine, doxorubicin and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 64: 2448-2458, 1989.
5. Mizuno S: Biological and medical grounds of combination with hyperthermia and radiotherapy. In: Hyperthermia Manual (in Japanese). Matsuda T (ed). Magupuros Publication Co., pp.1-5, 1991.
6. Mitsuhashi N: Positioning in combination therapy and future subjects. In: Hyperthermia - Guide Book of Hyperthermia for Cancer Therapy (in Japanese). Japanese Society for Thermal Medicine, Mainichi-kenkousaron Publication Co., pp.6-7, 2008.
7. Itoh Y, Kazaoka Y, Nitta M, et al: Combining anti-tumor drugs with mild hyperthermia increases the cytotoxic effects of drugs on human leukemia cells in vitro. Mol Med Rep 2: 411-415, 2009.
8. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
9. Zwelling LA and Kohn KW: Mechanism of action of cis-dichlorodiammineplatinum (II). Cancer Treat Rep 63: 1439-1444, 1979.
10. Di M: Adriamycin (NSC-123127): mode and mechanism of action. Cancer Chemother Rep 6: 91-106, 1975.
11. Nemoto T and Takahira H: Uptake of adriamycin into the cells and the interaction with DNA. Yakugakuzasshi (in Japanese) 93: 1498-1508, 1973.
12. 2+ in apoptosis induced by hyperthermia and its enhancement by verapamil in U937 cells. Int J Radiat Oncol 49: 1369-1379, 2001.
13. Hall EJ and Roizin T: Biological effects of heat. Cancer Res 44: S4708-S4713, 1984.
14. Shioura H, Hayashi S, Matsumoto H, et al: The effects of combined treatments with low hyperthermia and bleomycin on survival of murine Lcells. Clin Cancer Res 16: 147-152, 1997.
15. Kano E, Furukawa-Furuya M and Nitta K: Sensitivity of bleomycin-resistant variant cells enhanced by 40 °C hyperthermia in vitro. Int J Hyperthermia 4: 5547-5553, 1988.
16. Ono H, Ando S and Suzuki T: The drug uptake in the tumor with the mild-hyperthermia treatment in combination with the chemotherapy in vivo. Jpn J Hyperthermic Oncol 22: 23-33, 2006.
17. Huang Q, Hu JK and Lohr F: Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res 60: 3435-3439, 2000.
18. Urano M, Kuroda M and Nishimura Y: For the clinical application of thermal chemotherapy given at mild temperatures. Int J Hyperthermia 15: 79-107, 1999.
19. Ahmed K, Hori T and Yu DA: Hyperthermia chemo-sensitization, chemical thermo-sensitization and apoptosis. Thermal Med 24: 1-12, 2008.
20. Itoh Y, Tazawa K, Wada K, et al: Induction of HSP 70 in lymphocytes by whole body far-infrared hyperthermia. Jpn J Hyperthermic Oncol 21: 209-220, 2005.
21. Itoh Y, Ogawa K and Tazawa K: Improvement of athletic performances by heat shock protein 70 induced with mild hyperthermia. Jpn J Clin Physiol 38: 13-21, 2008.
22. Itoh Y and Yamada Y: Enhancement of the anti-tumor effects and improvement of QOLby the combination with mild hyperthermia. 67th Annual Meeting of the Japanese Cancer Association (JCA 2008) - Proceedings, p.361, 2008.
23. Yamada Y, Itoh Y and Honda Y: Increase of anti-tumor effect by combination therapy with mild hyperthermia and chemotherapy for bladder cancer. Thermal Med (in Japanese) 24: S65, 2008.
24. Yamada Y, Itoh Y, Aoki S, et al: Preliminary results of M-VACchemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium. Cancer Chemother Pharmacol 64: 1079-1083, 2009.